Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Nadai

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 17, 2013
[Changes in pharmacokinetics in elderly patients]Masayuki Nadai, Miki Katoh
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 21, 2022
Species and tissue differences in regorafenib glucuronidationAyaka Kojima, Masayuki Nadai, Miki Katoh
Biological & Pharmaceutical Bulletin|April 4, 2022
The Effect of Single-Walled Carbon Nanotubes on UDP-Glucuronosyltransferase 1A Activity in Human LiverYuki Asai, Masayuki Nadai, Miki Katoh
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 30, 2018
[Evaluation of Dissolution Profiles of Famotidine from OTC Drugs]Yuji Saito, Naoki Adachi, Miki Kato, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 12, 2022
Species differences in oxidative metabolism of regorafenibAyaka Kojima, Ayuka Sogabe, Masayuki Nadai, et al.
Biological & Pharmaceutical Bulletin|January 5, 2019
Effects of Thylakoid-Rich Spinach Extract on the Pharmacokinetics of Drugs in RatsYuji Saito, Tomoaki Usami, Miki Katoh, et al.
Biopharmaceutics & Drug Disposition|November 14, 2017
Effect of status epilepticus on expression of brain UDP-glucuronosyltransferase 1a in ratsYuki Asai, Hatsuna Tanaka, Masayuki Nadai, et al.
Journal of Pharmaceutical Sciences|November 28, 2017
Status Epilepticus Decreases Brain Cytochrome P450 2D4 Expression in RatsYuki Asai, Hatsuna Tanaka, Masayuki Nadai, et al.
Drug Metabolism and Pharmacokinetics|September 30, 2025
Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8Ayaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 4, 2015
Species and tissue differences in serotonin glucuronidationYukiko Sakakibara, Miki Katoh, Taisho Kawayanagi, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 17, 2013
[Changes in pharmacokinetics in elderly patients]Masayuki Nadai, Miki Katoh
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 21, 2022
Species and tissue differences in regorafenib glucuronidationAyaka Kojima, Masayuki Nadai, Miki Katoh
Biological & Pharmaceutical Bulletin|April 4, 2022
The Effect of Single-Walled Carbon Nanotubes on UDP-Glucuronosyltransferase 1A Activity in Human LiverYuki Asai, Masayuki Nadai, Miki Katoh
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 30, 2018
[Evaluation of Dissolution Profiles of Famotidine from OTC Drugs]Yuji Saito, Naoki Adachi, Miki Kato, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 12, 2022
Species differences in oxidative metabolism of regorafenibAyaka Kojima, Ayuka Sogabe, Masayuki Nadai, et al.
Biological & Pharmaceutical Bulletin|January 5, 2019
Effects of Thylakoid-Rich Spinach Extract on the Pharmacokinetics of Drugs in RatsYuji Saito, Tomoaki Usami, Miki Katoh, et al.
Biopharmaceutics & Drug Disposition|November 14, 2017
Effect of status epilepticus on expression of brain UDP-glucuronosyltransferase 1a in ratsYuki Asai, Hatsuna Tanaka, Masayuki Nadai, et al.
Journal of Pharmaceutical Sciences|November 28, 2017
Status Epilepticus Decreases Brain Cytochrome P450 2D4 Expression in RatsYuki Asai, Hatsuna Tanaka, Masayuki Nadai, et al.
Drug Metabolism and Pharmacokinetics|September 30, 2025
Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8Ayaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 4, 2015
Species and tissue differences in serotonin glucuronidationYukiko Sakakibara, Miki Katoh, Taisho Kawayanagi, et al.
Pageof 6